Adaptive designs for clinical trials assessing biomarker-guided treatment strategies. - Wikidata - wikimedia - TriplyDB

Adaptive designs for clinical trials assessing biomarker-guided treatment strategies.

Adaptive designs for clinical trials assessing biomarker-guided treatment strategies.

http://www.wikidata.org/entity/Q37711677

about

Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review Imaging biomarker roadmap for cancer studies Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives Clinical trial designs incorporating predictive biomarkers.Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer.Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review.Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.Working towards personalization in medicine: main obstacles to reaching this vision from today's perspective

P2860

Q26766584-2894A2FD-A3A4-4C72-A99C-C112A369F393 Q30242020-314B497D-61C5-49CE-AB63-A89C03DC1EA4 Q35182733-15A83E53-B0B7-4043-89CB-538848743EA7 Q36534713-26A6E37F-35AF-467A-A1B3-FE1D025E15A9 Q37060938-ED22FE5C-33AF-4780-A5D8-6C4CB2666EEC Q37731264-A812863C-B8F9-4249-8F42-B301D4028E7A Q38719665-FC7274CD-7D88-493F-82A4-F3B205CE41AB Q57899349-CCAD9F60-E667-49E9-AA96-4FC2B384B5ED

P2860

Adaptive designs for clinical trials assessing biomarker-guided treatment strategies.

http://www.wikidata.org/entity/Q37711677

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Adaptive designs for clinical trials assessing biomarker-guided treatment strategies.

@en

Adaptive designs for clinical trials assessing biomarker-guided treatment strategies.

@nl

type

label

Adaptive designs for clinical trials assessing biomarker-guided treatment strategies.

@en

Adaptive designs for clinical trials assessing biomarker-guided treatment strategies.

@nl

prefLabel

Adaptive designs for clinical trials assessing biomarker-guided treatment strategies.

@en

Adaptive designs for clinical trials assessing biomarker-guided treatment strategies.

@nl

P1433

Q37711677-D16E2995-45CC-4B39-844F-35E4EE7F8D4E

P1476

Q37711677-04ADBF8C-1296-4E55-897E-16AE8FA62512

P2093

Q37711677-65EE4A2B-F362-422C-AA02-921BABA57E34

Q37711677-BDE340A8-63DA-4103-A849-5B91266F2973

P2860

Q37711677-1B25892B-AE5D-441B-B7A7-A2B8F4A0F606

Q37711677-71F42624-01D6-4C8A-B224-4E2A7A05EBA6

Q37711677-75F3809E-BC39-4D11-9400-C5F420EDAF2F

Q37711677-7E5B1604-36CE-41D7-9529-6C56735F8A3C

Q37711677-857FF89D-6711-436D-8EF3-2A3591BC1C1C

Q37711677-8A183429-AB46-4194-9E27-C915C02AE7C3

Q37711677-8AABB924-55F5-41B3-8F53-A2CF3C2003AB

Q37711677-91F365FB-615E-4EE7-B586-7927D4812F6B

Q37711677-9D58887C-E5C8-4749-B061-6C0F9107A30A

Q37711677-9F86F020-6F68-49E6-9F23-3FE9C88DC0E7

P2888

Q37711677-181B420F-622F-49BF-A0DE-17210B00D07D

P304

Q37711677-701DDB04-8BB4-47C7-911E-6AA19977353F

P31

Q37711677-C81E4F90-4BD2-42A5-A91E-243CEAA17054

P356

Q37711677-9BC278F3-F6A3-46A1-816D-5BFA0A5240D2

P407

Q37711677-C03F7549-6FA0-4FDA-8F48-879703F932D1

P433

Q37711677-4B8AB2D9-B426-4E7C-ABD1-DE2F0C4A27D5

P478

Q37711677-CE6A72F7-91A6-4920-84D2-B0B976D07951

P50

Q37711677-2240D54D-DE09-4CB9-8A29-47518B1CCBF0

Q37711677-422AC72F-E36F-4B11-AF78-736117BA36C2

Q37711677-CB71A8A0-4E22-41E9-9F9D-D49E6CB5E99B

P577

Q37711677-834AD79F-7886-4A1B-87CF-F1729A6A2C66

P698

Q37711677-22256A46-FC10-40C0-A00E-E59962F4BF65

P921

Q37711677-B142BBD6-8E90-4E56-AD08-37B51BF4AEAE

P932

Q37711677-10C1D2E9-AE8D-4022-8D27-67B576451294

P356

P1433

British Journal of Cancer

P1476

Adaptive designs for clinical trials assessing biomarker-guided treatment strategies

@en

P2093

A Marshall

http://www.w3.org/2001/XMLSchema#string

J Dunn

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

A gene-expression signature as a predictor of survival in breast cancer

Molecular portraits of human breast tumours

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Supervised risk predictor of breast cancer based on intrinsic subtypes

Clinical trial designs for predictive marker validation in cancer treatment trials

Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology.

Bayesian adaptive design for targeted therapy development in lung cancer--a step toward personalized medicine.

P2888

P304

1950-1957

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2014.156

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24667651

http://www.w3.org/2001/XMLSchema#string

P921

P932

3992506

http://www.w3.org/2001/XMLSchema#string